| NCT ID | NCT05856539 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital for Special Surgery, New York |
| Condition | Patients With Spinal Stenosis Indicated for MIS TLIF |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2023-05-15 |
| Primary Completion | 2026-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2023-05-15 with a primary completion date of 2026-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, randomized controlled trial of patients undergoing minimally invasive transforaminal lumbar interbody fusion. This study will randomize patients into one of two groups: erector spinae plane (ESP) block and no ESP block.
Eligibility Criteria
Inclusion Criteria: * Age 18-80 * Patients scheduled for MIS TLIF (any level) with the principal investigator * ASA 1, 2, 3 Exclusion Criteria: * ASA 4 or higher * BMI \>40 * Chronic opioid use (daily use for \> 3 months) * Revision surgery, any history of previous lumbar spine surgery * Allergy to any of the study medications * Non-English speaking * Chronic renal insufficiency or failure (creatinine \>2) or severe hepatic disease (cirrhosis, failure) * Pregnancy * Any concomitant surgery
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05856539 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Patients With Spinal Stenosis Indicated for MIS TLIF. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05856539 currently recruiting?
Yes, NCT05856539 is actively recruiting participants. Contact the research team at gangh@hss.edu for enrollment information.
Where is the NCT05856539 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05856539 clinical trial?
NCT05856539 is sponsored by Hospital for Special Surgery, New York. The trial plans to enroll 48 participants.